News
New methodology paves the way for the Foundation's 2026 AMR Benchmark
28 January 2025
Avanti Gupta to share Foundation’s insights on AMR at the Bernstein European Sustainability Conference
Avanti Gupta, Investor Engagement Manager at the Access to Medicine Foundation, will deliver a keynote at Bernstein’s European Sustainability Conference in Paris. In the session titled “Infectious Diseases Putting Up Resistance,” she will underscore the urgency of antimicrobial resistance (AMR) and its implications for investors.
Date
18 March 2025
Location
Paris, France
The Bernstein European Sustainability Conference brings together institutional investors, corporates and financial institutions to explore the intersection of sustainability and global challenges, with a strong focus on health, climate and governance. This event presents a vital opportunity to elevate AMR as a key item on the Environmental Social and Governance investment agenda.
In her presentation, “The Silent Pandemic: Why Antimicrobial Resistance Threatens the Future of Humanity and How to Turn It into an Investment Opportunity,” Avanti will present AMR as both a public health emergency and a growing financial risk. Drawing on the Foundation’s research, she will outline how investors can mitigate these risks and drive sustainable solutions in pharmaceutical research and development, antibiotic stewardship and equitable access to medicines.
With AMR gaining recognition as a critical global health threat, this session will provide investors with actionable insights on mitigating risks and leveraging opportunities to foster long-term, sustainable impact.
